EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors

Yu Guo, Zheyuan Shen, Wenbin Zhao, Jialiang Lu, Yi Song, Liteng Shen, Yang Lu, Mingfei Wu, Qiuqiu Shi, Weihao Zhuang, Yueping Qiu, Jianpeng Sheng und 4 weitere

Advanced Science · 2024-04 · 11 (13)

DOI: 10.1002/advs.202306309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.01.2024. Verfasst von Yu Guo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou,…. Hauptthemen laut MEDLINE: Immunoconjugates. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R&D Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bystander‐killing payloads can significantly overcome the tumor heterogeneity issue and enhance the clinical potential of antibody‐drug conjugates (ADC), but the rational design and identification of effective bystander warheads constrain the broader implementation of this strategy. Here, graph attention networks (GAT) are constructed for a rational bystander killing scoring model and ADC construction workflow for the first time. To generate efficient bystander‐killing payloads, this model is utilized for score‐directed exatecan derivatives design. Among them, Ed9, the most potent payload with satisfactory permeability and bioactivity, is further used to construct ADC. Through linker optimization and conjugation, novel ADCs are constructed that perform excellent anti‐tumor efficacy and bystander‐killing effect in vivo and in vitro. The optimal conjugate T‐VEd9 exhibited therapeutic efficacy superior to DS‐8201 against heterogeneous tumors. These results demonstrate that the effective scoring approach can pave the way for the discovery of novel ADC with promising bystander payloads to combat tumor heterogeneity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesCell Line, Tumor

Stichwörter der Autor:innen

antibody‐drug conjugatesbystander‐killing effectcamptothecin derivativesrational designtumor heterogeneity

Substanzen

Immunoconjugates

Autor:innen und Institutionen

  • Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, P. R. China.
  • Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, Hangzhou, 310018, P. R. China.
  • The Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou, 310022, P. R. China.
  • Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310002, P. R. China.
  • Cancer Center, Zhejiang University, Hangzhou, 310058, P. R. China.
  • Department of Pharmacy, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, P. R. China.

ORCID-Profile: Xiaowu Dong

Förderung

  • Key R&D Program of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Guo, Y., Shen, Z., Zhao, W., Lu, J., Song, Y., Shen, L., Lu, Y., Wu, M., Shi, Q., Zhuang, W., Qiu, Y., Sheng, J., Zhou, Z., Fang, L., Che, J., & Dong, X. (2024). Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors. Advanced Science, 11(13). https://doi.org/10.1002/advs.202306309

Vancouver

Guo Y, Shen Z, Zhao W, Lu J, Song Y, Shen L, et al. Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors. Advanced Science. 2024;11(13). doi:10.1002/advs.202306309

BibTeX
@article{Guo2024,
  author = {Guo, Yu and Shen, Zheyuan and Zhao, Wenbin and Lu, Jialiang and Song, Yi and Shen, Liteng and Lu, Yang and Wu, Mingfei and Shi, Qiuqiu and Zhuang, Weihao and Qiu, Yueping and Sheng, Jianpeng and Zhou, Zhan and Fang, Luo and Che, Jinxin and Dong, Xiaowu},
  title = {Rational Identification of Novel Antibody‐Drug Conjugate with High Bystander Killing Effect against Heterogeneous Tumors},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {13},
  doi = {10.1002/advs.202306309}
}
Kostenlos starten →